Hypotheses about faster release of radiocopper-labeled NODAGA-TATE variants from tumor cells compared to [177Lu]Lu‐DOTA-TATE may address possible differences in downstream trafficking and metabolic fate of the ligand-SSTR2 complex. The gene discussed is SSTR2; the disease is neoplasm.